U.S. flag

An official website of the United States government

NM_000051.4(ATM):c.6067G>A (p.Gly2023Arg) AND Breast and/or ovarian cancer

Germline classification:
Likely benign (1 submission)
Last evaluated:
Mar 30, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001798320.11

Allele description [Variation Report for NM_000051.4(ATM):c.6067G>A (p.Gly2023Arg)]

NM_000051.4(ATM):c.6067G>A (p.Gly2023Arg)

Genes:
ATM:ATM serine/threonine kinase [Gene - OMIM - HGNC]
C11orf65:chromosome 11 open reading frame 65 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000051.4(ATM):c.6067G>A (p.Gly2023Arg)
Other names:
p.G2023R:GGA>AGA; NP_000042.3:p.Gly2023Arg
HGVS:
  • NC_000011.10:g.108315883G>A
  • NG_009830.1:g.98052G>A
  • NG_054724.1:g.158950C>T
  • NM_000051.4:c.6067G>AMANE SELECT
  • NM_001330368.2:c.641-6812C>T
  • NM_001351110.2:c.*39-6812C>T
  • NM_001351834.2:c.6067G>A
  • NP_000042.3:p.Gly2023Arg
  • NP_000042.3:p.Gly2023Arg
  • NP_001338763.1:p.Gly2023Arg
  • LRG_135t1:c.6067G>A
  • LRG_135:g.98052G>A
  • LRG_135p1:p.Gly2023Arg
  • NC_000011.9:g.108186610G>A
  • NM_000051.2:c.6067G>A
  • NM_000051.3:c.6067G>A
  • Q13315:p.Gly2023Arg
  • p.G2023R
Protein change:
G2023R
Links:
UniProtKB: Q13315#VAR_077238; dbSNP: rs11212587
NCBI 1000 Genomes Browser:
rs11212587
Molecular consequence:
  • NM_001330368.2:c.641-6812C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001351110.2:c.*39-6812C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000051.4:c.6067G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351834.2:c.6067G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Breast and/or ovarian cancer
Identifiers:
MedGen: CN221562

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002042698CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Mar 30, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario, SCV002042698.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024